197 related articles for article (PubMed ID: 23557284)
1. Upcycling drugs for brain-related diseases: a sustainable future for targeted drug delivery.
de Boer M; Visser CC; Gaillard PJ
Ther Deliv; 2013 Apr; 4(4):435-8. PubMed ID: 23557284
[No Abstract] [Full Text] [Related]
2. Nano-enabled delivery systems across the blood-brain barrier.
Hwang SR; Kim K
Arch Pharm Res; 2014 Jan; 37(1):24-30. PubMed ID: 24170511
[TBL] [Abstract][Full Text] [Related]
3. Challenges and new strategies for therapeutic peptide delivery to the CNS.
McGowan JW; Bidwell GL; Vig PJ
Ther Deliv; 2015 Jul; 6(7):841-53. PubMed ID: 26228775
[TBL] [Abstract][Full Text] [Related]
4. Polymeric nanocarriers for controlled and enhanced delivery of therapeutic agents to the CNS.
Gagliardi M; Bardi G; Bifone A
Ther Deliv; 2012 Jul; 3(7):875-87. PubMed ID: 22900468
[TBL] [Abstract][Full Text] [Related]
5. A review of the potential role of nano-enabled drug delivery technologies in amyotrophic lateral sclerosis: lessons learned from other neurodegenerative disorders.
Mazibuko Z; Choonara YE; Kumar P; Du Toit LC; Modi G; Naidoo D; Pillay V
J Pharm Sci; 2015 Apr; 104(4):1213-29. PubMed ID: 25559087
[TBL] [Abstract][Full Text] [Related]
6. Experimental study on biodegradable polymer-paclitaxel conjugate micelles for chemotherapy of C6 glioma.
Wang Z; Hu X; Yue J; Jing X
J Control Release; 2011 Nov; 152 Suppl 1():e41-2. PubMed ID: 22195914
[No Abstract] [Full Text] [Related]
7. Differential receptor-mediated drug targeting to the diseased brain.
Rip J; Schenk GJ; de Boer AG
Expert Opin Drug Deliv; 2009 Mar; 6(3):227-37. PubMed ID: 19327042
[TBL] [Abstract][Full Text] [Related]
8. Exosome delivered anticancer drugs across the blood-brain barrier for brain cancer therapy in Danio rerio.
Yang T; Martin P; Fogarty B; Brown A; Schurman K; Phipps R; Yin VP; Lockman P; Bai S
Pharm Res; 2015 Jun; 32(6):2003-14. PubMed ID: 25609010
[TBL] [Abstract][Full Text] [Related]
9. EPR-effect: utilizing size-dependent nanoparticle delivery to solid tumors.
Stylianopoulos T
Ther Deliv; 2013 Apr; 4(4):421-3. PubMed ID: 23557281
[No Abstract] [Full Text] [Related]
10. Peptide pills for brain diseases? Reality and future perspectives.
Serrano Lopez DR; Lalatsa A
Ther Deliv; 2013 Apr; 4(4):479-501. PubMed ID: 23557289
[TBL] [Abstract][Full Text] [Related]
11. Current advances in delivery of biotherapeutics across the blood-brain barrier.
Rajadhyaksha M; Boyden T; Liras J; El-Kattan A; Brodfuehrer J
Curr Drug Discov Technol; 2011 Jun; 8(2):87-101. PubMed ID: 21513485
[TBL] [Abstract][Full Text] [Related]
12. Nanogels as potential drug nanocarriers for CNS drug delivery.
Vashist A; Kaushik A; Vashist A; Bala J; Nikkhah-Moshaie R; Sagar V; Nair M
Drug Discov Today; 2018 Jul; 23(7):1436-1443. PubMed ID: 29775669
[TBL] [Abstract][Full Text] [Related]
13. Polymeric nanoparticles for the drug delivery to the central nervous system.
Tosi G; Costantino L; Ruozi B; Forni F; Vandelli MA
Expert Opin Drug Deliv; 2008 Feb; 5(2):155-74. PubMed ID: 18248316
[TBL] [Abstract][Full Text] [Related]
14. Influence of the surface properties on nanoparticle-mediated transport of drugs to the brain.
Kreuter J
J Nanosci Nanotechnol; 2004 May; 4(5):484-8. PubMed ID: 15503433
[TBL] [Abstract][Full Text] [Related]
15. [New methods of drug delivery through the blood brain barrier].
Bruhn C
Dtsch Med Wochenschr; 2012 May; 137(21):p18. PubMed ID: 22622506
[No Abstract] [Full Text] [Related]
16. Nanotechnology-based drug delivery for central nervous system disorders.
Nguyen TT; Dung Nguyen TT; Vo TK; Tran NM; Nguyen MK; Van Vo T; Van Vo G
Biomed Pharmacother; 2021 Nov; 143():112117. PubMed ID: 34479020
[TBL] [Abstract][Full Text] [Related]
17. The 12th Conference on the Formulation and Delivery of Bioactives.
Tucker IG
Ther Deliv; 2010 Jul; 1(1):25-7. PubMed ID: 22816116
[TBL] [Abstract][Full Text] [Related]
18. The targeted delivery of cancer drugs across the blood-brain barrier: chemical modifications of drugs or drug-nanoparticles?
Juillerat-Jeanneret L
Drug Discov Today; 2008 Dec; 13(23-24):1099-106. PubMed ID: 18848640
[TBL] [Abstract][Full Text] [Related]
19. Large amino acid transporter 1 (LAT1) prodrugs of valproic acid: new prodrug design ideas for central nervous system delivery.
Peura L; Malmioja K; Laine K; Leppänen J; Gynther M; Isotalo A; Rautio J
Mol Pharm; 2011 Oct; 8(5):1857-66. PubMed ID: 21770378
[TBL] [Abstract][Full Text] [Related]
20. Improving the transport of chemotherapeutic drugs across the blood-brain barrier.
Orthmann A; Fichtner I; Zeisig R
Expert Rev Clin Pharmacol; 2011 Jul; 4(4):477-90. PubMed ID: 22114857
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
